Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Key Projections for the CAGR of the Crohn’s Disease (CD) Treatment Market Size From 2025 to 2034?

The market size for treatment of Crohn’s disease (cd) has seen a consistent rise over the past years. It’s projected to leap from $11.76 billion in 2024 to $12.32 billion in 2025, boasting a compound annual growth rate (CAGR) of 4.8%. This observable growth through the historic era can be credited to an increase in cases of Crohn’s disease, a burgeoning understanding of the ailment, groundwork initiatives by the government, and lifestyle modifications.

The market size for the treatment of Crohn’s disease (CD) is predicted to experience robust growth in the upcoming years. It is projected to reach $15.01 billion in 2029, with a compound annual growth rate (CAGR) of 5.1%. This substantial increase during the forecast period can be credited to a rising demand for combination therapies, enhanced adoption of biologics, and significant investment in research and development for Crohn’s disease (CD) treatments. Within the forecast period, major trends are expected to revolve around the development of biologic drugs, inventive products, sophisticated diagnostic tools, and the adoption of biosimilars.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12902&type=smp

Which Primay Drivers Are Accelerating Growth in the Crohn’s Disease (CD) Treatment Market?

The growth of the Crohn’s disease (CD) treatment market is anticipated to be accelerated by the rising prevalence of inflammatory bowel diseases. These are a set of chronic inflammatory conditions predominantly influencing the gastrointestinal (GI) tract. Treatment of Crohn’s disease aims to alleviate symptoms, mitigate inflammation, foster remission, and improve the overall quality of life for those afflicted by chronic inflammatory bowel disease. In September 2023, the US-based United States National Library of Medicine estimated the incidence of inflammatory bowel diseases (IBD) in Canada to be about 30 per 100,000 person-years in 2023, with an expected regular increment of nearly 0.58% annually. By the year 2023, the occurrence of IBD in Canada was about 825 per 100,000, with predictions indicating a potential rise to 1.1% of the population by 2035. Consequently, the escalating incidence of inflammatory bowel diseases propels the growth of the Crohn’s disease (CD) treatment market.

Which Primary Segments of the Crohn’s Disease (CD) Treatment Market Are Driving Growth and Industry Transformations?

The crohn’s disease (cd) treatmentmarket covered in this report is segmented –

1) By Drug Type: Antibiotics; Amino Salicylates; Corticosteroids; Immunomodulators; Other Drug Types

2) By Route of Administration: Oral; Injectable

3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Drug Stores

Subsegments:

1) By Antibiotics: Metronidazole; Ciprofloxacin; Rifaximin

2) By Amino Salicylates: Mesalamine; Sulfasalazine

3) By Corticosteroids: Prednisone; Budesonide; Hydrocortisone

4) By Immunomodulators: Azathioprine; Mercaptopurine; Methotrexate

5) By Other Drug Types: Biologic Therapies; Janus Kinase Inhibitors; Small Molecules

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=12902&type=smp

Which Regions Are Key Players in the Growth of the #Which Primay Drivers Are Accelerating Growth in the Crohn’s Disease (CD) Treatment Market?# Market?

North America was the largest region in the Crohn’s disease (CD) treatment market in 2024. The regions covered in Crohn’s disease (CD) treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Which Technological Trends Are Reshaping the Crohn’s Disease (CD) Treatment Industry Dynamics?

Leading firms in the Crohn’s Disease (CD) treatment market are leveraging new technologies like IBDSENSE to maintain their market position. In March 2023, The IRR Chemistry Hub, an interdisciplinary hub based in Scotland, pioneered the development of IBDSENSE. The goal of this technology is to enhance the diagnosis and monitoring of inflammatory bowel disease using non-invasive techniques, including those applied to Crohn’s disease. The approach involves the use of fluorescence-based technology to determine the enzyme activity of Granzyme B (GzmB) in the biosamples sourced from patients. The inception of this technology is projected to better the patient’s experience and widen the range of treatment options.

View the full report here:

https://www.thebusinessresearchcompany.com/report/crohns-disease-cd-treatment-global-market-report

What Parameters Are Used to Define the Crohn’s Disease (CD) Treatment Market?

Crohn’s disease (CD) is an inflammatory bowel disease (IBD) that causes inflammation and swelling of the tissues in the digestive tract. Crohn’s disease (CD) treatment involves various approaches, therapies, medications and interventions to manage and control the symptoms and complications of a chronic inflammatory condition.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12902

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model